GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (NYSE:DHR) » Definitions » Cyclically Adjusted PB Ratio

DHR (Danaher) Cyclically Adjusted PB Ratio : 3.43 (As of Jul. 08, 2025)


View and export this data going back to 1978. Start your Free Trial

What is Danaher Cyclically Adjusted PB Ratio?

As of today (2025-07-08), Danaher's current share price is $200.68. Danaher's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $58.51. Danaher's Cyclically Adjusted PB Ratio for today is 3.43.

The historical rank and industry rank for Danaher's Cyclically Adjusted PB Ratio or its related term are showing as below:

DHR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.55   Med: 3.97   Max: 7.45
Current: 3.41

During the past years, Danaher's highest Cyclically Adjusted PB Ratio was 7.45. The lowest was 2.55. And the median was 3.97.

DHR's Cyclically Adjusted PB Ratio is ranked worse than
73.72% of 137 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.88 vs DHR: 3.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Danaher's adjusted book value per share data for the three months ended in Mar. 2025 was $71.058. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $58.51 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Danaher Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Danaher's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Cyclically Adjusted PB Ratio Chart

Danaher Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.39 6.93 4.91 4.37 4.02

Danaher Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.57 4.50 4.93 4.02 3.50

Competitive Comparison of Danaher's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Danaher's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Danaher's Cyclically Adjusted PB Ratio falls into.


;
;

Danaher Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Danaher's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=200.68/58.51
=3.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Danaher's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=71.058/134.9266*134.9266
=71.058

Current CPI (Mar. 2025) = 134.9266.

Danaher Quarterly Data

Book Value per Share CPI Adj_Book
201506 35.262 100.684 47.255
201509 33.731 100.392 45.335
201512 34.494 99.792 46.638
201603 35.586 100.470 47.790
201606 36.271 101.688 48.127
201609 33.533 101.861 44.418
201612 33.231 101.863 44.018
201703 34.269 102.862 44.951
201706 35.397 103.349 46.212
201709 36.485 104.136 47.273
201712 37.838 104.011 49.085
201803 38.926 105.290 49.883
201806 38.891 106.317 49.357
201809 39.488 106.507 50.025
201812 40.221 105.998 51.198
201903 41.851 107.251 52.651
201906 42.662 108.070 53.264
201909 43.028 108.329 53.592
201912 41.224 108.420 51.302
202003 42.260 108.902 52.359
202006 46.523 108.767 57.712
202009 48.843 109.815 60.012
202012 51.333 109.897 63.024
202103 52.098 111.754 62.900
202106 55.321 114.631 65.115
202109 56.239 115.734 65.565
202112 58.600 117.630 67.217
202203 60.179 121.301 66.939
202206 61.762 125.017 66.658
202209 62.257 125.227 67.079
202212 66.475 125.222 71.627
202303 68.308 127.348 72.373
202306 70.058 128.729 73.431
202309 70.926 129.860 73.694
202312 72.357 129.419 75.436
202403 72.160 131.776 73.885
202406 68.919 132.554 70.153
202409 71.030 133.029 72.043
202412 68.896 133.157 69.812
202503 71.058 134.927 71.058

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Danaher  (NYSE:DHR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Danaher Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Danaher's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher Business Description

Address
2200 Pennsylvania Avenue, North West, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Executives
Steven M Rales director, officer: Chairman 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Alan G Spoon director 1150 15TH ST NW, WASHINGTON DC 20071
Brian W Ellis officer: Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20037
Daniel Raskas officer: VP-Corporate Development 2099 PENNSYLVANIA AVENUE, NORTHWEST, WASHINGTON DC 20006
Georgeann Couchara officer: SVP, Human Resources 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Linda Filler director 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON DC 20037
Matthew Mcgrew officer: EVP & Chief Financial Officer 2200 PENNSYLVANIA AVENUE, NW, SUITE 800 W, WASHINGTON DC 20010
Rainer Blair officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Joakim Weidemanis officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Walter G Lohr director DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Teri List director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Jose-carlos Gutierrez-ramos officer: SVP, Chief Scientific Officer C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Raymond C Stevens director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Jennifer Honeycutt officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Feroz Dewan director C/O ARENA HOLDINGS MANAGEMENT LLC, 119 FIFTH AVENUE - 8TH FLOOR, NEW YORK NY 10003